Related Experiment Video

Updated: Jul 20, 2026

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

Heart rate slowing for myocardial dysfunction/heart failure

Paul Mulder1, Christian Thuillez

  • 1INSERM U644, Faculté de Médecine et de Pharmacie, Rouen, France.

Advances in Cardiology
|August 29, 2006
PubMed

Insights

Reducing heart rate in heart failure patients using ivabradine improved cardiac function. This effect persisted after treatment withdrawal, suggesting intrinsic myocardial improvements from pure heart rate reduction.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure prevalence is increasing, with elevated heart rate contributing to cardiac dysfunction.
  • The impact of isolated heart rate reduction on heart failure progression remains unclear.

Purpose of the Study:

  • To investigate the effects of pure heart rate reduction on cardiac function in a rat model of heart failure.
  • To determine if chronic heart rate reduction improves intrinsic myocardial function.

Main Methods:

  • Utilized a rat model of heart failure.
  • Administered ivabradine, an I(f) channel blocker, to reduce heart rate without altering blood pressure.
  • Evaluated cardiac function and myocardial tissue characteristics after chronic ivabradine treatment.

Main Results:

  • Ivabradine dose-dependently reduced heart rate, improving cardiac function.
  • Improved cardiac function persisted after ivabradine withdrawal, indicating enhanced intrinsic myocardial function.
  • Potential mechanisms include improved oxygen supply-demand ratio and reduced myocardial collagen accumulation.

Conclusions:

  • Pure, chronic heart rate reduction can be beneficial in managing heart failure.
  • Ivabradine's effects suggest a therapeutic potential for isolated heart rate lowering in heart failure.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...